Modernizing non-classical protein crystallization through industry 4.0: Advanced monitoring and modelling utilizing process analytical technology

Modernizing manufacturing processes of pharmaceutical drug products with advanced monitoring and modelling can aid in the transition towards Industry 4.0 with the benefit of increased productivity. This study investigated the use of process analytical technology in combination with partial least squ...

Full description

Saved in:
Bibliographic Details
Published in:Chemical engineering research & design Vol. 204; pp. 382 - 389
Main Authors: Jul-Jørgensen, I., Oliver, R., Gernaey, K.V., Hundahl, C.A.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-04-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Modernizing manufacturing processes of pharmaceutical drug products with advanced monitoring and modelling can aid in the transition towards Industry 4.0 with the benefit of increased productivity. This study investigated the use of process analytical technology in combination with partial least squares (PLS) regressions to create two soft sensors to predict the mass fraction of crystallised active pharmaceutical ingredient (API) and mass fraction of dissolved API during a non-classical protein crystallization with amorphous precursors. The PLS model for predicting the amount of crystalline API was based on Raman spectra, chord length distributions and turbidity data using small-angle X-ray scattering as a reference method. The model had a root mean square error on cross-validation (RMSECV) of 5 %. The model predicting mass fraction of dissolved API was based only on the Raman spectra and used high performance liquid chromatography as reference method. This model had a RMSECV of 3 % A two-step nucleation model was fitted to the predictions from the sensors and showed good agreement between data and model with a root mean square error of 2 %. [Display omitted] •Process Analytical Technology applied to amorphous phase-mediated crystallization.•Raman spectra, chord length distributions and turbidity predicts mass fractions.•Even small changes in mass fractions are detected during crystallization.•Good agreement between data and fitted model.•PAT-mediated process optimization.
ISSN:0263-8762
DOI:10.1016/j.cherd.2024.02.037